Diagnostic and Interventional Cardiology reports that men undergoing testosterone therapy had a 29 percent greater risk of heart attack, stroke and death according to a study of a "real world" population of men. An accompanying editorial in JAMA by an endocrinologist with the Perelman School of Medicine at the University of Pennsylvania notes that the mounting evidence of a signal of cardiovascular risk warrants cautious testosterone prescribing and additional investigation.
An estimated 2.9 percent of U.S. men over 40 years old are prescribed testosterone therapy, yet there are limited randomized trial data examining the long term benefits and risks.
The experienced attorneys at Schachter, Hendy & Johnson, P.S.C. are taking cases where people who took testosterone therapy drugs, including AndroGel, Androderm, and Testrim, suffered a heart attack, stroke or death. If you or a loved one suffered a heart attack or stroke after undergoing testosterone therapy, please call our office for a free consultation.